603858 Shandong Buchang Pharmaceuticals
- 12.98
- -1.44-9.99%
Shandong Buchang Pharmaceuticals News
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the completion of medical device business license change registration for its holding subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the holding subsidiary obtaining a notice of acceptance of drug registration
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Announcement of the progress of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the completion of industrial and commercial change registration for its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on changes in the pharmaceutical production license of its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the reduction of registered capital and related transactions of the holding subsidiary
Announcement of Resolutions of the Second Meeting of the Fifth Board of Supervisors of Shandong Buchang Pharmaceutical Co., Ltd.
Special report on the storage and actual use of funds raised in the 2024 semi-year of Shandong Buchang Pharmaceutical Co., Ltd.
Shandong Buchang Pharmaceutical Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Shandong Buchang Pharmaceutical Co., Ltd.
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on changes in the business scope of its subsidiary
Announcement of Resolutions of the Third Meeting of the Fifth Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Announcement from Shandong Buchang Pharmaceuticals Co., Ltd. regarding the pharmaceutical production permit change of its wholly-owned subsidiary.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. regarding its controlling subsidiary, Lanzhou Buchang, signing the Distributing and Licensing Agreement on Injection BC001 with LANCET.
Special legal opinions from Beijing Jindu (Qingdao) Law Firm regarding the differentiated dividends of Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement of Implementation of Equity Distribution of Shandong Buchang Pharmaceuticals Co., Ltd. for the Year 2023.
Analysis
Price Target
No Data
